Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures

Clinical trial NCT04485104 · TERMINATED

Trial details

NCT number: NCT04485104
Sponsor: Jazz Pharmaceuticals
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Seizure in Participants With Tuberous Sclerosis Complex Seizure in Participants With Dravet Syndrome Seizure in Participants With Lennox-Gastaut Syndrome

Start date: 2021-05-19
Primary completion: 2025-01-28
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.